In Business Madison: UW researchers provide key data for brain imaging marker
A brain imaging marker used by researchers at the University of Wisconsin School of Medicine and Public Health is now moving to the commercial world following its approval by the Food and Drug Administration, the university announced on Thursday.
The development is considered an important step in how Alzheimer’s disease is evaluated in patients.
Wisconsin researchers were among the earliest adopters of the brain imaging agent, called MK-6240.
It is now marketed as TAUKLARIFY, and it allows clinicians to visualize the buildup of tau, a protein closely associated with Alzheimer’s disease.
Click here to read full article.